Assoc. Prof. Dr. Masood Rabieh | Operational Research | Best Researcher Award

Published on by Superior Awards

Assoc. Prof. Dr. Masood Rabieh | Operational Research | Best Researcher Award

Assoc. Prof. Dr. Masood Rabieh , Shahid Beheshti University ,Iran.

Dr. Masood Rabieh is a seasoned academic in Industrial Management with a specialization in Operational Research. He is currently a faculty member at the Department of Management and Accounting at Shahid Beheshti University 📘. With a strong background in systems thinking, sustainable operations, and innovation modeling, he has authored impactful research and co-authored a groundbreaking book on platform strategy 🌍. His scholarly contributions span numerous top-tier journals 📚. Dr. Rabieh is passionate about using analytical tools to solve real-world organizational problems and continues to shape academic thought in industrial and systems engineering ⚙️📈.

Publication Profile

Scopus
Google Scholar

Education & Experience

📘 Education:
🧑‍🏫 Academic & Professional Experience:

  • 📆 2011–2021: Researcher and faculty member

  • 📆 2014–Present: Active researcher in operational research and management

  • 📆 2017–2020: Contributor to national innovation capability initiatives

  • 📆 2021–2023: Focus on systems excellence and strategic transformation

Summary Suitability

Dr. Masood Rabieh is exceptionally well-qualified for the Best Researcher Award, given his sustained contributions to the advancement of Industrial Management and Operational Research. With a Ph.D. from Tarbiat Modares University and an academic position at Shahid Beheshti University, Dr. Rabieh has built a distinguished research profile that bridges theoretical rigor and practical relevance.

Professional Development 

Dr. Rabieh has consistently pursued academic and professional growth through interdisciplinary research, collaboration, and publishing in renowned journals 📰. His work in systems dynamics, decision-making models, and sustainability showcases his commitment to applied knowledge 💡. He has collaborated with experts across domains to enhance innovation, optimize supply chains, and develop national policy models 🏛️. As a mentor and author 📖, Dr. Rabieh has influenced the academic and corporate sectors alike. His recent book on platform strategy reflects his forward-thinking approach to business model innovation 💼🌐. He actively contributes to knowledge networks and scholarly communities 📊🤝.

Research Focus 

📚 Dr. Rabieh’s research primarily lies at the intersection of operational research, systems thinking, and strategic decision-making ⚙️🧠. He focuses on complex modeling to optimize supply chains, improve national innovation systems, and support sustainable management practices 🌿📦. His work often incorporates simulation, multi-criteria decision-making, and social network analysis to deliver actionable insights 📉🔍. Notably, his studies on energy demand, pharmaceutical logistics, and dynamic scorecards demonstrate his capability to solve pressing industrial and societal challenges 🌍🔬. His contributions support both academic progress and real-world impact, especially in emerging economies and policy design 🧮📈.

Awards and Honors

🏅 Awards & Honors:

  • 🏆 Recognized for outstanding contribution to systems thinking and operational research

  • 📖 Author of an acclaimed book on platform strategy, published in 2022

  • 🌟 Featured in high-impact journals such as Systems Research and Behavioral Science and Annals of Operations Research

  • 🧠 Acknowledged as a key contributor in national innovation capability modeling

  • 📚 Collaborated with top scholars in multi-disciplinary decision-making projects

Publication Top Notes

  1. An MINLP Model for Project Scheduling with Feeding Buffer
    Authors: Ashkan Ayough, Masood Rabieh, Mohammad Naeem Javadi, Behrooz Khorshidvand
    Journal: International Journal of Applied Decision Sciences
    Year: 2024

  2. Designing Sustainable Distribution Network in Pharmaceutical Supply Chain: A Case Study
    Authors: Nassibeh Janatyan, Mostafa Zandieh, Akbar Alem-Tabriz, Masood Rabieh
    Journal: International Journal of Supply and Operations Management, Vol. 5, No. 2, pp. 122–133
    Year: 2018
    Citations: 44

  3. Sustainable Supplier Selection and Order Allocation: An Integrated Delphi Method, Fuzzy TOPSIS and Multi-Objective Programming Model
    Authors: Masood Rabieh, Abbas Fadaei Rafsanjani, Leila Babaei, Mahdi Esmaeili
    Journal: Scientia Iranica, Vol. 26, No. 4, pp. 2524–2540
    Year: 2019
    Citations: 33

  4. A Robust Optimization Model for Sustainable Pharmaceutical Distribution Network Design: A Case Study
    Authors: Nassibeh Janatyan, Mostafa Zandieh, Akbar Alem-Tabriz, Masood Rabieh
    Journal: Annals of Operations Research, pp. 1–20
    Year: 2021
    Citations: 22

  5. Ethics in Management Science
    Authors: A. Azar, Masood Rabieh, F. Ghiasi
    Journal: Ethics in Science and Technology, Vol. 3, No. 12, pp. 61–75
    Year: 2008
    Citations: 20

  6. Optimizing Sustainable Pharmaceutical Distribution Network Model with Evolutionary Multi-Objective Algorithms (Case Study: Darupakhsh Company)
    Authors: Nassibeh Janatyan, Mostafa Zandieh, Akbar Alem-Tabriz, Masood Rabieh
    Journal: Research in Production and Operations Management, Vol. 10, No. 1, pp. 133–153
    Year: 2019
    Citations: 17

  7. Robust-Fuzzy Model for Supplier Selection Under Uncertainty: An Application to the Automobile Industry
    Authors: Masood Rabieh, M. Modarres, A. Azar
    Journal: Scientia Iranica, Vol. 25, No. 4, pp. 2297–2311
    Year: 2018
    Citations: 15

Conclusion

Dr. Masood Rabieh deserving the qualities of a Best Researcher Award recipient. His research has not only advanced scholarly discourse but has also informed strategic practices in both the public and private sectors. His interdisciplinary collaborations, high-impact publications, and commitment to addressing complex societal and industrial challenges make him an outstanding candidate for this prestigious recognition.

 

Prof. Dr. Pablo Torres Rodas | Structural Engineering | Best Researcher Award

Published on by Superior Awards

Prof. Dr. Pablo Torres Rodas | Structural Engineering | Best Researcher Award

Prof. Dr. Pablo Torres Rodas , Universidad San Francisco de Quito , Ecuador.

Dr. Pablo Torres Rodas 🇪🇨 is a civil and structural engineering expert with deep roots in academia and industry. Currently a professor at Universidad San Francisco de Quito 🎓, he earned his Ph.D. from the University of California, Irvine 🇺🇸, where he also served as a teaching assistant. His work blends theory and practice, focusing on performance-based earthquake engineering 🌍⚙️. With experience spanning construction inspection, design, and education, Dr. Torres Rodas has contributed significantly through research publications and teaching 📚. His dedication to seismic safety and structural reliability positions him as a leader in engineering resilience 🏗️🔬.

Publication Profile

Scopus
Google Scholar

Education & Experience 

🎓 Education:
👨‍🏫 Teaching Experience:

  • 📐 Geometry TA – Universidad de Cuenca (2005–2007)

  • 🧱 Lecturer: Concrete & Statistics – Universidad de Cuenca (2013)

  • 🌍 Earthquake Eng. TA – UC Irvine (2016)

  • 🏗️ Steel Design TA – UC Irvine (2017)

  • 🌲 Timber Design TA – UC Irvine (2018)

  • 🎓 Structural Engineering Lecturer – USFQ (2018–present)

👷‍♂️ Professional Experience:

  • 🛠️ Civil Construction Inspector – Coca-Codo-Sinclair Dam

  • 🧱 Construction Supervisor – Municipio de Nabón

  • 🚧 Infrastructure Projects – Cuenca, Ecuador

  • 🏢 Structural Design – Various buildings in Cuenca

Summary Suitability

Dr. Pablo Torres Rodas is a leading candidate for the Best Researcher Award due to his exceptional contributions to the field of structural and earthquake engineering. As a professor at Universidad San Francisco de Quito, Dr. Torres Rodas has consistently demonstrated research excellence, academic leadership, and impactful innovation. His work focuses on the development of analytical and numerical models that advance Performance-Based Earthquake Engineering (PBEE) — a critical area for building resilience in seismic-prone regions.

Professional Development 

Dr. Torres Rodas is committed to ongoing professional growth through teaching, research, and real-world structural engineering 🌐🏗️. At Universidad San Francisco de Quito, he educates future engineers while advancing analytical and numerical modeling in seismic performance studies 📊📘. His international academic journey, from Ecuador to the U.S., reflects a dedication to excellence and cross-cultural collaboration 🌎🤝. His published research in leading ASCE journals 📄🧠 contributes to safer, more resilient structures. He actively bridges theoretical knowledge with applied engineering, emphasizing innovative methods in structural analysis and design under seismic loading conditions 🌋📐.

Research Focus 

Dr. Torres Rodas’s research lies in Performance-Based Earthquake Engineering (PBEE), a field that seeks to enhance structural safety and resilience during seismic events 🌍🏢. His work centers on developing both analytical and numerical models to simulate how structures respond to earthquake-induced forces 📉💥. By exploring column base connection behaviors and embedded connection stiffness, he contributes critical knowledge to structural engineering design standards 📚⚙️. His insights help engineers design buildings that can better withstand tremors, minimizing damage and saving lives. His goal is to merge academic rigor with real-world safety innovation 🔬🏗️.

Awards and Honors

  • 🎓 SENESCYT Scholarship – Awarded by the Ecuadorian government for doctoral studies abroad (2013–2017)

  • 🏅 Best Lecturer Award – College of Science and Engineering, Universidad San Francisco de Quito (2019–2020)

Publication Top Notes

  • Torres-Rodas, P., Fayaz, J., Medalla, M. (2024). Statistical evaluation of steel moment frames response under crustal and subduction seismic environments. Journal of Building Engineering.

  • Torres-Rodas, P., Flores, F., Pozo, S., Astudillo, B.X. (2021). Seismic performance of steel moment frames considering the effects of column-base hysteretic behavior and gravity framing system. Soil Dynamics and Earthquake Engineering, 144, 106654.

  • Hassan, A.S., Torres-Rodas, P., Giulietti, L., Kanvinde, A. (2021). Strength characterization of exposed column base plates subjected to axial force and biaxial bending. Engineering Structures, 237, 112165.

  • Torres-Rodas, P., Fayaz, J., Zareian, F. (2020). Strength resistance factors for seismic design of exposed base plate connections in special steel moment resisting frames. Earthquake Spectra, 36(2), 537–553.

  • Villacreses, J.P., Granados, J., Caicedo, B., Torres-Rodas, P., Yépez, F. (2021). Seismic and hydromechanical performance of rammed earth walls under changing environmental conditions. Construction and Building Materials, 300, 124331.

Conclusion

Dr. Torres Rodas exemplifies the qualities of a best-in-class researcher: innovation, interdisciplinary collaboration, and societal impact. His groundbreaking work enhances the global understanding of seismic design, making infrastructure safer and more resilient. With a strong publication record, international engagement, and ongoing contributions to engineering science, he is highly deserving of the Best Researcher Award.

Mr. Tianxiang Wu | Bioinformatics | Best Researcher Award

Published on by Superior Awards

Mr. Tianxiang Wu | Bioinformatics | Best Researcher Award

Mr. Tianxiang Wu , China Pharmaceutical University , China.

Mr. Tianxiang Wu 🎓, is a passionate pharmacology researcher 🔬 currently pursuing his Master’s degree at China Pharmaceutical University 🏫. With a strong foundation in pharmacy from Binzhou Medical University 💊, he has demonstrated exceptional skills in molecular biology, immunology, and bioinformatics 🧪💻. His cutting-edge research on TRPM8-mediated exosome release in prostatitis 🧬 has led to first-author publications in respected journals 📚. Known for his proficiency in experimental techniques and scientific tools 🛠️, Tianxiang is committed to advancing treatments for chronic inflammatory conditions 🧠. His analytical mindset and dedication make him a rising star in biomedical research 🌟.

Publication Profile

Orcid

Education & Experience 

  • 🎓 Master’s Candidate in Pharmacology (2023.09–Present), China Pharmaceutical University

  • 🎓 Bachelor’s in Pharmacy (2019.09–2023.06), Binzhou Medical University

  • 🧪 Researcher on TRPM8 and Exosome Release in Type III Prostatitis

  • 🐁 Experienced in murine model establishment, H&E staining, and cell sorting

  • 🧬 Skilled in WB, ELISA, immunofluorescence, flow cytometry, and EV isolation

  • 💻 Setup and managed cloud server for bioinformatics and network pharmacology tools

  • 🧠 Authored publications in immunology and peptide research journals

Summary Suitability

Mr. Tianxiang Wu is a compelling nominee for the Best Researcher Award owing to his exceptional contributions to pharmacological research, molecular immunology, and translational bioinformatics. As a Master’s candidate in Pharmacology at China Pharmaceutical University, Wu has demonstrated academic excellence and research leadership far beyond his years. His ability to integrate experimental biology with advanced computational tools marks him as a standout early-career scientist with high impact potential.

Professional Development 

Mr. Tianxiang Wu has actively enhanced his scientific and technical proficiency through hands-on research and bioinformatics innovation 🧬💻. He has mastered diverse experimental techniques including Western blotting, immunofluorescence, and flow cytometry 🔍. His competence with software like GraphPad Prism, SPSS, and FlowJo 📊 strengthens his analytical capabilities. Beyond lab skills, Tianxiang played a key role in establishing a lab-based cloud server for high-throughput bioinformatics analysis ☁️🧠. His dual focus on wet lab precision and digital research tools makes him a well-rounded scientist 🌐. He continuously seeks to integrate immunological insights with translational medicine for future therapeutic innovations 💡.

Research Focus 

Mr. Tianxiang Wu’s research lies at the intersection of immunopharmacology, molecular biology, and bioinformatics 🧪🧬💻. His current focus on TRPM8-related exosome signaling in Type III prostatitis aims to decode immune tolerance pathways and identify oral vaccine candidates for chronic pelvic pain syndrome 💊🔬. By combining molecular docking, antigen epitope prediction, and experimental validation, his work bridges basic immunological mechanisms with translational therapy goals 🔄🧠. His interest in extracellular vesicles, immune modulation, and peptide-based immunotherapy positions his research squarely in immunotherapeutics and inflammation-related pharmacology 🌡️🧫. He is shaping the future of personalized and precise inflammation control through innovative biological insight 🌟.

Awards & Honors 

  • 🥇 First Author – Review article in Journal of Immunology Research

  • 🏅 First Author – Experimental study accepted by International Journal of Peptide Research and Therapeutics

  • 🌐 Lab Innovator – Set up and managed bioinformatics cloud server for research team

  • 🧠 Research Contributor – Key developer of TRPM8-based antigen epitope vaccine strategy

Publication Top Notes

  1. 🔬 A 619-pixel Machine Vision Enhancement Chip Based on Two-Dimensional Semiconductors

    • 🗞️ Journal: Science Advances

    • 📅 Publication Date: 2022-08-05

    • 🧾 DOI: 10.1126/sciadv.abn9328

    • 👥 Contributors: Shunli Ma, Tianxiang Wu, Xinyu Chen, Yin Wang, Jingyi Ma, Honglei Chen, Antoine Riaud, Jing Wan, Zihan Xu, Lin Chen, et al.

    • 📌 Role: Co-author

    • 🧠 Summary: This paper presents a novel 619-pixel imaging chip built on 2D semiconductors, pushing the limits of machine vision enhancement.

  1. 🧬 Immune Tolerance Regulation Is Critical to Immune Homeostasis

    • 🗞️ Journal: Journal of Immunology Research

    • 🖋️ Role: First Author

    • 📘 Type: Review Article

    • 🧠 Summary: Explores mechanisms and therapeutic importance of immune tolerance in maintaining immune system balance.

  1. 💉 Specific TRPM8-Ⅱ Antigen Determinant Clusters as an Oral Vaccine Prevent Chronic Prostatitis/Chronic Pelvic Pain Syndrome through Induction of Immune Tolerance

    • 🗞️ Journal: International Journal of Peptide Research and Therapeutics

    • 📘 Type: Experimental Research Article

    • 🖋️ Role: First Author

    • 📌 Status: Accepted for Publication

    • 🧠 Summary: Demonstrates a novel oral peptide-based vaccine targeting TRPM8 to treat CP/CPPS through immune tolerance mechanisms.

Conclusion

Mr. Tianxiang Wu diverse, impactful, and innovative research trajectory, combined with his publication record and laboratory leadership, makes him exceptionally well-suited for the Best Researcher Award. His work not only contributes novel insights into immune mechanisms but also opens translational pathways for precision therapies targeting chronic inflammatory diseases.

Mr. Hossein Soltani Nejad | Nanotechnology | Best Researcher Award

Published on by Superior Awards

Mr. Hossein Soltani Nejad | Nanotechnology | Best Researcher Award

Mr. Hossein Soltani Nejad , Department of Stem Cells Technology and Tissue Regeneration, Faculty of Interdisciplinary Science and Technologies, Tarbiat Modares University, Iran.

Mr. Hossein Soltani Nejad is a dedicated faculty member at Tarbiat Modares University 🏫, specializing in gene therapy and disease diagnostics using the CRISPR/Cas system 🧬. His cutting-edge work involves nanocarriers for precise gene delivery 🚀. With a postdoctoral background in editing hematopoietic stem cells for immunodeficiency disorders 👶 and a Ph.D. in nanobiotechnology focusing on cancer diagnostics 🎯, he continues to contribute significantly to biomedical innovation. Mr. Soltani has collaborated with esteemed institutions, including the University of Nebraska Medical Center 🇺🇸, and is passionate about translational research bridging bench to bedside 🧑‍⚕️🔬.

Publication Profile

Scopus
Orcid

Education & Experience 

  • 🎓 Ph.D. in Nanobiotechnology – University of Isfahan (2018): Focused on DNA methylation-based diagnostics for colorectal cancer.

  • 🧪 Postdoctoral Research – Tehran University of Medical Sciences (2020–2021): CRISPR editing of stem cells in immunodeficiency patients.

  • 🌍 Research Fellowship – UNMC, USA (2017): CRISPR-based GFP gene insertion in human cells.

  • 👨‍🏫 Faculty Member – Department of Stem Cell Technology and Tissue Regeneration, Tarbiat Modares University.

Summary Suitability

Mr. Hossein Soltani Nejad is an outstanding candidate for the Best Researcher Award, due to his innovative contributions in the fields of gene therapy, disease diagnosis, and nanotechnology. His specialized expertise in utilizing the CRISPR/Cas9 system for genome editing and applying nanocarriers for gene delivery places him at the forefront of cutting-edge research in molecular medicine and biotechnology. As a faculty member at the Department of Stem Cell Technology and Tissue Regeneration at Tarbiat Modares University, Mr. Soltaninejad’s work has directly contributed to advancements in precision medicine, therapeutic strategies for genetic disorders, and the development of novel treatments for chronic diseases, including cancer, autoimmune disorders, and Parkinson’s disease.

Professional Development 

Mr. Soltani Nejad continually enriches his expertise through multidisciplinary collaborations and translational research projects 🧬🧠. He engages in animal and cellular modeling for diseases such as Parkinson’s and hemophilia 🐁, employs cutting-edge nanotechnology for drug delivery and diagnostics ⚗️, and contributes to clinical trials in regenerative medicine 💉. He collaborates with multiple medical universities across Iran and the Pasteur Institute 🏥, advancing therapeutic platforms that integrate CRISPR systems, stem cells, and targeted delivery technologies 🚀. His commitment to innovation and patient-centered solutions keeps him at the forefront of molecular medicine and gene therapy development 🌟.

Research Focus 

Mr. Soltani Nejad’s research centers on gene therapy and regenerative medicine, with a focus on CRISPR/Cas genome editing 🧬, stem cell therapy 🌱, and nanotechnology-based delivery systems 🧫. His work addresses a broad spectrum of diseases, including hemophilia, Parkinson’s disease, cancer, and infectious diseases like COVID-19 💊. By integrating biomaterials such as PEG-PLGA and functionalized peptides, he explores innovative methods for precise and effective therapeutic delivery 🚑. His approach bridges fundamental science with clinical application, aiming to develop targeted, less invasive treatments for genetic and degenerative conditions across medical disciplines 🧠🦴🫁.

Awards & Honors 

  • 🏆 Co-Author of Highly Cited Review Article – “Clinical applications of the CRISPR/Cas9 genome-editing system”, published in Journal of Genes & Diseases, 2024.

  • 🧬 Lead Contributor on CRISPR and Precision Medicine Integration – Recognized for authoring pivotal reviews on CRISPR, CAR-T, and AI in gene therapy (2023).

  • 📘 Noted for Innovation in DNA Methylation Detection – Author of novel research using gold/silver nanoclusters in fluorescence-based cancer diagnostics (2018–2019).

  • 🌟 Early Career Research Excellence – Published internationally during postdoctoral and research fellowship phases in collaboration with global institutions (UNMC, TUMS).

  • 🌐 International Research Collaboration in Plant Pathology – Contributing author to a genetic study on citrus canker published with French researchers (2015).

  • 🧪 Recognized Contributor in Stem Cell and Nanomedicine – Co-authored clinical and experimental studies on stem cell sorting and nanoparticle-based drug delivery.

Publication Top Notes

  • Khoshandam, M., Soltaninejad, H., Hamidieh, A. A., & Hosseinkhani, S. (2024, July). CRISPR, CAR-T, and NK: Current applications and future perspectives. Genes & Diseases, [ISSN: 2352-3042]. https://doi.org/10.1016/j.gendis.2023.101121

  • Khoshandam, M., Soltaninejad, H., Mousazadeh, M., Hamidieh, A. A., & Hosseinkhani, S. (2024, January). Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine. Genes & Diseases, [ISSN: 2352-3042]. https://doi.org/10.1016/j.gendis.2023.02.027

  • Zare-Zardini, H., Hatamizade, N., Haddadzadegan, N., Soltaninejad, H., & Karimi-Zarchi, M. (2022). Advantages and disadvantages of using carbon nanostructures in reproductive medicine: Two sides of the same coin. JBRA Assisted Reproduction, [ISSN: 1518-0557]. https://doi.org/10.5935/1518-0557.20210070

  • Farhangfar, S., Fesahat, F., Zare-Zardini, H., Dehghan-Manshadi, M., Zare, F., Mirsmaeili, S. M., Vajihinejad, M., & Soltaninejad, H. (2022, December). In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer. Iranian Journal of Basic Medical Sciences. https://doi.org/10.22038/ijbms.2022.66065.14524

  • Parsaeian, M. R., Haji Shabani, A. M., Dadfarnia, S., Zare-Zardini, H., Soltaninejad, H., & Forouzani-Moghaddam, M. J. (2022, October). Evaluating the biological activities of functionalized magnetic iron oxide nanoparticles with different concentrations of aqueous pine leaves extract. Journal of the Indian Chemical Society, [ISSN: 0019-4522]. https://doi.org/10.1016/j.jics.2022.100707

  • Zare-Zardini, H., Soltaninejad, H., Ghorani-Azam, A., Nafisi-Moghadam, R., Haddadzadegan, N., Ansari, M., Saeed-Banadaki, S. H., Sobhan, M. R., Mozafari, S., & Zahedi, M. (2022, September). Slow release curcumin-containing soy protein nanoparticles as anticancer agents for osteosarcoma: Synthesis and characterization. Progress in Biomaterials, [ISSN: 2194-0509, 2194-0517]. https://doi.org/10.1007/s40204-022-00197-4

Conclusion

Mr. Hossein Soltani nejad exemplifies the qualities of a Best Researcher Award recipient through his unwavering commitment to impactful, translational science. His contributions bridge fundamental research and clinical innovation, addressing some of today’s most pressing medical challenges. With a robust academic background, international collaborations, and a portfolio of multidisciplinary projects, he is a leading force in biomedical research deserving of this prestigious recognition.